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Immunizations During Pregnancy
The time has come when physicians may be able to practice preventive medicine,
which is particularly important in reference to those infectious diseases that can be
prevented by immunizations. Even pregnant women should be candidates for
certain immunizations. It is the scope of this editorial to cover just two of those
immunizations that can be prescribed for pregnant women: the influenza vaccine
and the hepatitis B vaccine.
The influenza vaccine is changed on a yearly basis to immunize against the
strains expected to cause disease that season. Although the influenza vaccine is
available, it is often not prescribed or used in the pregnant patient. There are
several reasons for not prescribing it during pregnancy, one of which is the
physician’s fear of medical/legal consequences. Another reason is that patients who
have a bad outcome during pregnancy may have recall bias and blame the unfortu-
nate outcome on a specific circumstance, drug, or immunization. Although this
cause and effect is almost never the case, it is certainly difficult to convince the
patient of this point. However, physicians should be proactive in offering the
influenza vaccine to those patients who may suffer the highest complication rates,
namely, patients who are severe asthmatics or those with heart disease. Therefore,
we should remind ourselves, particularly in the northern hemisphere of the United
States, that in the months of October and November before the winter flu season,
we should offer the influenza vaccine to patients who have entered the second
trimester or more of pregnancy without fear that the vaccine will cause a fetal
problem.
The hepatitis B vaccine, now offered in a recombinant form, should be made
available to our female population, especially to individuals who either have a life
style that may increase their risk of acquiring hepatitis B infection, such as health
care workers, or live in a community where there is a high prevalence of hepatitis,
such as in a large inner-city population. Unfortunately, the cost of the hepatitis B
vaccine for an adult is approximately $ 5 0 per dose, with each patient requiring 3
doses over a course of 6 months. For this reason, the cost factor has limited the use
of the hepatitis B vaccine. With the current active support of the Academy of
Pediatrics to immunize newborns and children with the hepatitis B vaccine, many
individuals may be immunized in the future. However, until that point is reached,
we should offer immunization to women who are considered high risk, preferably
before they get pregnant, and remember that pregnancy is not a contraindication
for the hepatitis B vaccine.
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